Mingxin China Growth Fund is an international private equity fund, focusing on growth stage companies in China and looking for investment.
Mingxin China Growth Fund is a venture capital firm specializing in growth and expansion stage investments. The firm typically invests in telecommunication, media, technologies; consumer goods and services; healthcare, pharmaceuticals and biotech; clean tech; advanced manufacturing; agriculture; education; and business and financial services sectors. It seeks to invest in companies based in China. Mingxin China Growth Fund is based in Beijing, China with additional offices in Shanghai, China; Shandong, China; Central, Hong Kong; and Palo Alto, California.
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Dec 7, 2019
Remegen
|
Private Equity(PE) | — | Biotechnology | — |
Oct 15, 2015
PegBio
|
Series C | ¥7M | Health Care | — |
Feb 12, 2014
Oorja Fuel Cells
|
Series E | $3.45M | Energy | Yes |
Jul 25, 2013
Percent
|
Series B | $10M | Analytics | — |
Jul 25, 2011
Percent
|
Series A | $7.20M | Analytics | — |